Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3211 AL 3225

Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?

Ambermoon P, Carter A, Hall W, Dissanayaka N, O'Sullivan J.

Addiction. 2012 Feb;107(2):241-7. doi: 10.1111/j.1360-0443.2011.03511.x. Epub 2011 Jul 27.

Is depression in Parkinson's disease (PD) a specific entity?

Even C, Weintraub D.

J Affect Disord. 2012 Jul;139(2):103-12. doi: 10.1016/j.jad.2011.07.002. Epub 2011 Jul 26.

Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease

Palada V, Terzić J, Mazzulli J, Bwala G, Hagenah J, Peterlin B, Hung AY, Klein C, Krainc D.

Neurobiol Aging. 2012 Apr;33(4):836.e1-3. doi: 10.1016/j.neurobiolaging.2011.06.015. Epub 2011 Jul 27.

Modulation of inhibition of return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype

Rokem A, Landau AN, Prinzmetal W, Wallace DL, Silver MA, D'Esposito M.

Cereb Cortex. 2012 May;22(5):1133-8. doi: 10.1093/cercor/bhr185. Epub 2011 Jul 28.

Subsystems of sensory attention for skilled reaching: vision for transport and pre-shaping and somatosensation for grasping, withdrawal and release

Sacrey LA, Whishaw IQ.

Behav Brain Res. 2012 Jun 1;231(2):356-65. doi: 10.1016/j.bbr.2011.07.031. Epub 2011 Jul 22.

Valosin-containing protein mutation and Parkinson's disease

Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, Kimonis V.

Parkinsonism Relat Disord. 2012 Jan;18(1):107-9. doi: 10.1016/j.parkreldis.2011.07.006. Epub 2011 Aug 3.

Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease

Tolosa E, Stern MB.

Eur J Neurol. 2012 Feb;19(2):258-64. doi: 10.1111/j.1468-1331.2011.03484.x. Epub 2011 Aug 5.

Biophysics of α-synuclein membrane interactions

Pfefferkorn CM, Jiang Z, Lee JC.

Biochim Biophys Acta. 2012 Feb;1818(2):162-71. doi: 10.1016/j.bbamem.2011.07.032. Epub 2011 Jul 28.

Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study

Ricchi V, Zibetti M, Angrisano S, Merola A, Arduino N, Artusi CA, Rizzone M, Lopiano L, Lanotte M.

Brain Stimul. 2012 Jul;5(3):388-392. doi: 10.1016/j.brs.2011.07.001. Epub 2011 Jul 31.

Co-occurrence of progressive anarthria with an S393L TARDBP mutation and ALS within a family

Praline J, Vourc'h P, Guennoc AM, Veyrat-Durebex C, Corcia P.

Amyotroph Lateral Scler. 2012 Jan;13(1):155-7. doi: 10.3109/17482968.2011.598168. Epub 2011 Aug 11.

Doctor, is it Parkinson's disease?

Wojtecki L, Ringelstein M, Südmeyer M, Schnitzler A.

Parkinsonism Relat Disord. 2012 Jan;18(1):113-4. doi: 10.1016/j.parkreldis.2011.07.005. Epub 2011 Aug 10.

Involvement of the spinal cord in Parkinson's disease

Raudino F, Leva S.

Int J Neurosci. 2012 Jan;122(1):1-8. doi: 10.3109/00207454.2011.613551. Epub 2011 Sep 12.

Aberrant striatal synaptic plasticity in monogenic parkinsonisms

Madeo G, Martella G, Schirinzi T, Ponterio G, Shen J, Bonsi P, Pisani A.

Neuroscience. 2012 Jun 1;211:126-35. doi: 10.1016/j.neuroscience.2011.07.065. Epub 2011 Aug 2.

Oscillatory activity in the globus pallidus internus: comparison between Parkinson's disease and dystonia

Weinberger M, Hutchison WD, Alavi M, Hodaie M, Lozano AM, Moro E, Dostrovsky JO.

Clin Neurophysiol. 2012 Feb;123(2):358-68. doi: 10.1016/j.clinph.2011.07.029. Epub 2011 Aug 16.

Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up

Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, Guaglio G, Perini M, Comi C, Balbi P, Maestri R.

Neurorehabil Neural Repair. 2012 Feb;26(2):144-50. doi: 10.1177/1545968311416990. Epub 2011 Aug 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias